CVS Stock - CVS Health Corporation
Unlock GoAI Insights for CVS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B |
| Gross Profit | $51.40B | $54.43B | $54.50B | $52.12B | $49.05B |
| Gross Margin | 13.8% | 15.2% | 16.9% | 17.8% | 18.3% |
| Operating Income | $8.52B | $13.74B | $7.95B | $13.31B | $13.91B |
| Net Income | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B |
| Net Margin | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% |
| EPS | $3.66 | $6.49 | $3.29 | $6.00 | $5.48 |
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 14th 2025 | Goldman | Initiation | Buy | $91 |
| August 18th 2025 | UBS | Upgrade | Buy | $79 |
| August 14th 2025 | Robert W. Baird | Upgrade | Outperform | $82 |
| February 13th 2025 | Leerink Partners | Upgrade | Outperform | $75← $55 |
| February 12th 2025 | Cantor Fitzgerald | Upgrade | Overweight | - |
| January 30th 2025 | Edward Jones | Upgrade | Buy | - |
| December 3rd 2024 | Deutsche Bank | Upgrade | Buy | $66 |
| November 18th 2024 | Wells Fargo | Upgrade | Overweight | $66← $60 |
| October 10th 2024 | Barclays | Upgrade | Overweight | $82← $63 |
| October 4th 2024 | TD Cowen | Upgrade | Buy | $85← $59 |
| May 30th 2024 | Robert W. Baird | Initiation | Neutral | $61 |
| May 7th 2024 | TD Cowen | Downgrade | Hold | $59← $99 |
| May 2nd 2024 | UBS | Downgrade | Neutral | $60← $85 |
| May 1st 2024 | Cantor Fitzgerald | Downgrade | Neutral | - |
| May 1st 2024 | Leerink Partners | Downgrade | Market Perform | $60← $87 |
Earnings History & Surprises
CVSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 11, 2026 | $0.99 | — | — | — |
Q4 2025 | Oct 29, 2025 | $1.37 | $1.60 | +16.8% | ✓ BEAT |
Q3 2025 | Jul 31, 2025 | $1.46 | $1.81 | +24.0% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $1.70 | $2.25 | +32.4% | ✓ BEAT |
Q1 2025 | Feb 12, 2025 | $0.91 | $1.19 | +30.2% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $1.44 | $1.09 | -24.3% | ✗ MISS |
Q3 2024 | Aug 7, 2024 | $1.73 | $1.83 | +5.8% | ✓ BEAT |
Q2 2024 | May 1, 2024 | $1.70 | $1.31 | -22.9% | ✗ MISS |
Q1 2024 | Feb 7, 2024 | $2.01 | $2.12 | +5.5% | ✓ BEAT |
Q4 2023 | Nov 1, 2023 | $2.13 | $2.21 | +3.8% | ✓ BEAT |
Q3 2023 | Aug 2, 2023 | $2.12 | $2.21 | +4.2% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $2.07 | $2.20 | +6.3% | ✓ BEAT |
Q1 2023 | Feb 8, 2023 | $1.92 | $1.99 | +3.6% | ✓ BEAT |
Q4 2022 | Nov 2, 2022 | $1.99 | $2.09 | +5.0% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $2.17 | $2.40 | +10.6% | ✓ BEAT |
Q2 2022 | May 4, 2022 | $2.15 | $2.22 | +3.3% | ✓ BEAT |
Q1 2022 | Feb 9, 2022 | $1.94 | $1.98 | +2.1% | ✓ BEAT |
Q4 2021 | Nov 3, 2021 | $1.79 | $1.97 | +10.1% | ✓ BEAT |
Q3 2021 | Aug 4, 2021 | $2.06 | $2.42 | +17.5% | ✓ BEAT |
Latest News
President Trump Says We Could Get Insurance Companies To Cut Prices To Stay In System; I Will Call Meeting Of Insurance Companies To Get Their Price Down; Meeting In Coming Weeks
📈 PositiveJP Morgan Maintains Overweight on CVS Health, Raises Price Target to $101
📈 PositiveBernstein Maintains Market Perform on CVS Health, Raises Price Target to $87
➖ NeutralTruist Securities Maintains Buy on CVS Health, Raises Price Target to $98
📈 PositivePiper Sandler Reiterates Overweight on CVS Health, Raises Price Target to $101
📈 PositiveBarclays Maintains Overweight on CVS Health, Raises Price Target to $93
📈 PositiveMizuho Maintains Outperform on CVS Health, Raises Price Target to $95
📈 PositiveMorgan Stanley Maintains Overweight on CVS Health, Raises Price Target to $93
📈 PositiveBaird Maintains Outperform on CVS Health, Raises Price Target to $92
📈 PositiveCVS Health Corp Says 2026 Total Revenue To Decline 3.5% Largely Due To Exit From Obamacare Business
📉 NegativeCVS shares are trading higher after the company raised its FY2025 adjusted EPS and sales guidance.
📈 PositiveCVS Health Expects To Achieve A Mid-teens Adjusted EPS CAGR Through 2028
📈 PositiveCVS Health Sees FY2026 GAAP EPS $5.94-$6.14 vs $5.86 Est
📈 PositiveCVS Health Sees FY2026 Adj EPS $7.00-$7.20 vs $7.18 Est; Sees Sales Of At Least $400B vs $409.911B Est
➖ NeutralCVS Health Raises FY2025 GAAP EPS Guidance from $(0.34)-$(0.24) to $(0.32)-$(0.22) vs $3.96 Est
➖ NeutralCVS Health Raises FY2025 Adj EPS Guidance from $6.55-$6.65 to $6.60-$6.70 vs $6.38 Est; Raises FY2025 Sales Guidance from At Least $397.3B to $400B vs $394.594B Est
📈 PositiveBernstein Maintains Market Perform on CVS Health, Raises Price Target to $86
➖ NeutralU.S. Attorney In Manhattan Announces $37.8M Settlement With CVS For Over Dispensing Insulin Pens To Patients
📉 NegativeReuters: Some States Operating ACA Marketplaces Say Enrollment Is Significantly Down From Same Period Last Year, California Says ACA Enrollment Down By 33% vs Last Year
📉 NegativeCVS Health Board Elects President And CEO David Joyner As Chair Of The Board, Effective January 1, 2026
📈 PositiveFrequently Asked Questions about CVS
What is CVS's current stock price?
What is the analyst price target for CVS?
What sector is CVS Health Corporation in?
What is CVS's market cap?
Does CVS pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to CVS for comparison